328 related articles for article (PubMed ID: 22083525)
1. Lysine acetylation in obesity, diabetes and metabolic disease.
Iyer A; Fairlie DP; Brown L
Immunol Cell Biol; 2012 Jan; 90(1):39-46. PubMed ID: 22083525
[TBL] [Abstract][Full Text] [Related]
2. Acetylation in cardiovascular diseases: Molecular mechanisms and clinical implications.
Yang M; Zhang Y; Ren J
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165836. PubMed ID: 32413386
[TBL] [Abstract][Full Text] [Related]
3. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.
Yang XJ; Seto E
Oncogene; 2007 Aug; 26(37):5310-8. PubMed ID: 17694074
[TBL] [Abstract][Full Text] [Related]
4. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
[TBL] [Abstract][Full Text] [Related]
5. Histone Acetylation Enzymes Coordinate Metabolism and Gene Expression.
Shen Y; Wei W; Zhou DX
Trends Plant Sci; 2015 Oct; 20(10):614-621. PubMed ID: 26440431
[TBL] [Abstract][Full Text] [Related]
6. K-acetylation and its enzymes: overview and new developments.
Aka JA; Kim GW; Yang XJ
Handb Exp Pharmacol; 2011; 206():1-12. PubMed ID: 21879443
[TBL] [Abstract][Full Text] [Related]
7. NMR profiling of histone deacetylase and acetyl-transferase activities in real time.
Dose A; Liokatis S; Theillet FX; Selenko P; Schwarzer D
ACS Chem Biol; 2011 May; 6(5):419-24. PubMed ID: 21302972
[TBL] [Abstract][Full Text] [Related]
8. Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease.
Li P; Ge J; Li H
Nat Rev Cardiol; 2020 Feb; 17(2):96-115. PubMed ID: 31350538
[TBL] [Abstract][Full Text] [Related]
9. Chemical and structural biology of protein lysine deacetylases.
Yoshida M; Kudo N; Kosono S; Ito A
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(5):297-321. PubMed ID: 28496053
[TBL] [Abstract][Full Text] [Related]
10. The role of histone deacetylases in embryonic development.
Dsilva P; Pai P; Shetty MG; Babitha KS
Mol Reprod Dev; 2023 Jan; 90(1):14-26. PubMed ID: 36534913
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protein turnover by acetyltransferases and deacetylases.
Sadoul K; Boyault C; Pabion M; Khochbin S
Biochimie; 2008 Feb; 90(2):306-12. PubMed ID: 17681659
[TBL] [Abstract][Full Text] [Related]
12. Lysine Deacetylases and Regulated Glycolysis in Macrophages.
Shakespear MR; Iyer A; Cheng CY; Das Gupta K; Singhal A; Fairlie DP; Sweet MJ
Trends Immunol; 2018 Jun; 39(6):473-488. PubMed ID: 29567326
[TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases.
Dekker FJ; van den Bosch T; Martin NI
Drug Discov Today; 2014 May; 19(5):654-60. PubMed ID: 24269836
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylases in memory and cognition.
Penney J; Tsai LH
Sci Signal; 2014 Dec; 7(355):re12. PubMed ID: 25492968
[TBL] [Abstract][Full Text] [Related]
15. [Assay for inhibitory activity of histone deacetylase].
Yoshida M
Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
[TBL] [Abstract][Full Text] [Related]
16. Targeting histone deacetylases for the treatment of disease.
Lawless MW; Norris S; O'Byrne KJ; Gray SG
J Cell Mol Med; 2009 May; 13(5):826-52. PubMed ID: 19175682
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors target diabetes via chromatin remodeling or as chemical chaperones?
Lawless MW; O'Byrne KJ; Gray SG
Curr Diabetes Rev; 2009 Aug; 5(3):201-9. PubMed ID: 19689255
[TBL] [Abstract][Full Text] [Related]
18. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
[TBL] [Abstract][Full Text] [Related]
19. Roles of histone acetyltransferases and deacetylases in gene regulation.
Kuo MH; Allis CD
Bioessays; 1998 Aug; 20(8):615-26. PubMed ID: 9780836
[TBL] [Abstract][Full Text] [Related]
20. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.
Schuetze KB; McKinsey TA; Long CS
J Mol Cell Cardiol; 2014 May; 70():100-7. PubMed ID: 24631770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]